FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
How It Works
What People Say
Patient reviews across 6 platforms
Articles
Symptoms
What your body is telling you
Treatments
Protocols, prescriptions, therapies
Longevity
Medicine 3.0 strategies
Heart Health & Risk
Protect your heart & vessels
Metabolism
Insulin, blood sugar, weight
Hormones
TRT, thyroid, menopause, andropause
Performance
VO2 max, muscle, sleep, gut
Playbooks
Step-by-step frameworks
About
Meet Dr. Ash
Your Physician
GERO·SPAN
Our Clinical Framework
FAQ
Common Questions
Book a Free Call
Weight Loss That Actually Works
Fishtown Medicine•7 min read

Weight Loss That Actually Works

We do not chase a number on a scale. We focus on metabolic health, muscle preservation, and a relationship with food that brings freedom, not shame.

On This Page
  • Why "Calories In, Calories Out" Misses the Point
  • How We Approach Medical Weight Loss
  • 1. Metabolic and Hormonal Audit
  • 2. GLP-1 Medications (Semaglutide and Tirzepatide)
  • 3. Muscle Protection
  • What Tests Do We Run Before Starting?
  • Guidance from the Clinic
  • Common Questions
  • Are GLP-1 medications safe?
  • Do you guarantee weight loss?
  • Will I gain the weight back if I stop GLP-1s?
  • How is this different from a regular weight loss clinic?
  • Can I qualify for GLP-1s with my insurance?
  • What is the difference between Wegovy and Zepbound?
  • Do I need to exercise on GLP-1s?
  • What about microdosing GLP-1s?
  • How fast is the weight loss?
  • What happens if I miss a dose?
  • Deep Questions
  • What is "Ozempic face" and how do you prevent it?
  • Why is visceral fat more dangerous than subcutaneous fat?
  • How does sleep affect weight loss?
  • Why do some women struggle to lose weight despite eating well?
  • What is leptin resistance?
  • How does the menstrual cycle affect weight loss?
  • Can you lose weight in perimenopause?
  • What is the role of the gut microbiome in weight?
  • How does insulin resistance prevent weight loss?
  • What about GLP-1 medications and muscle loss?
  • Is bariatric surgery ever the right answer?
  • How do you handle weight regain after weight loss?
  • What is "set point theory" in weight regulation?
  • How does chronic stress prevent weight loss?
  • Are compounded semaglutide and tirzepatide safe?
  • What labs should I retest while on a GLP-1?
  • Why does weight come off easier in the first month?
  • Can children and teens take GLP-1 medications?
  • Scientific References

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR · 30-second take

Medical weight loss is a clinical approach that addresses the hormones, behaviors, and labs behind weight gain. We use tools like GLP-1 medications (Wegovy, Zepbound), lab work, body composition scans, and resistance training. The goal is to lower visceral fat while keeping muscle, not just to lose weight on the scale.

Medical Weight Loss & Body Composition in Philadelphia

TL;DR: "Eat less, move more" ignores how the body actually works. Chronic weight problems are a hormonal and neurological issue, not a willpower problem. We use lab work, GLP-1 medications when appropriate, body composition scans, and a structured plan to build a healthier engine, not just a smaller body.

Why "Calories In, Calories Out" Misses the Point

The old advice oversimplifies a complex system. Your hormones (insulin, leptin, ghrelin) defend a "set point" weight that the brain treats as normal. When you diet, the body lowers metabolism and raises hunger to bring you back to that set point. Most diets fail for this reason, not because of weak willpower. At Fishtown Medicine, we use the term body recomposition. The goal is to lose visceral fat (the deep belly fat around organs that drives heart and metabolic disease) while preserving or building muscle.

How We Approach Medical Weight Loss

We follow Health At Every Size (HAES) principles by focusing on health behaviors and metabolic markers, not on judging anyone by BMI. The plan has three layers.

1. Metabolic and Hormonal Audit

Before talking about medications, we fix the foundation. We check for:
  • Insulin resistance (a state where cells stop responding well to insulin)
  • Slow thyroid function
  • High cortisol (the stress hormone)
  • Low testosterone in men
  • Leptin resistance (a state where the brain stops registering "I am full")
We treat what we find before adding medications.

2. GLP-1 Medications (Semaglutide and Tirzepatide)

GLP-1 receptor agonists (a class of medications that mimic a gut hormone called GLP-1) include Wegovy, Ozempic, Zepbound, and Mounjaro. They quiet "food noise" in the brain, slow stomach emptying, and lower blood sugar. We prescribe them carefully and pair them with a plan to protect muscle and meet protein needs.

3. Muscle Protection

Rapid weight loss without resistance training often costs you 20% to 40% of weight from lean muscle. That is a long-term loss for a short-term win. We require resistance training, high protein intake, and DEXA scan tracking to make sure you are losing the right kind of weight.

What Tests Do We Run Before Starting?

Standard labs miss most of the action. Our intake includes:
TestWhat It Tells Us
Fasting insulinInsulin resistance often shows up here years before A1c rises
HOMA-IRA calculated score of insulin sensitivity
Full thyroid panelTSH, free T3, free T4, antibodies (most labs only check TSH)
LeptinA hormone that signals fullness; resistance is common in chronic weight gain
Sex hormonesLow testosterone in men, PCOS markers in women
Cortisol patternSaliva or urine timing across the day
DEXA scanBody composition: fat, muscle, bone, visceral fat

Guidance from the Clinic

"If you lose 30 pounds but lose 10 pounds of muscle, you have a smaller body and a weaker metabolism. Our job is to help you lose fat while keeping the parts that drive your health forward."
A common question I hear: "Will I have to take this medication forever?" My honest answer: it depends. For some patients, GLP-1s are long-term tools, the same way blood pressure medications are. For others, the medication helps reset food behavior and metabolic markers, and we can taper it once the new patterns are stable. We plan the off-ramp from day one.

Scientific References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. The STEP 1 trial.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. The SURMOUNT-1 trial.
  3. Rosenstock J, et al. Effect of Tirzepatide vs Semaglutide on Glycemia and Body Weight. N Engl J Med. 2021;385(6):503-515.
  4. Heymsfield SB, et al. Effect of Once-Weekly Semaglutide on Lean Body Mass. Diabetes Obes Metab. 2024.
  5. Ryan DH, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nat Med. 2024.
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right weight management plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.

Frequently Asked Questions

Common Questions

GLP-1 medications are generally safe for most patients, with strong cardiovascular outcome data showing reduced heart attack and stroke risk. Common side effects include nausea, constipation, and reflux, especially in the first weeks. Rare but serious risks include pancreatitis and gallbladder issues. We monitor closely and adjust dosing to limit problems.
No medical provider can guarantee weight loss. We can guarantee a thorough plan, evidence-based tools, and close follow-up. Most patients who follow the full plan lose meaningful weight, often 10% to 20% of starting weight, but individual results vary based on biology, labs, and behavior change.
Most patients regain some weight after stopping GLP-1 medications, typically 30% to 50% of what was lost within a year. The amount depends on muscle mass built, eating habits, and metabolic flexibility achieved. That is why we focus on building durable habits and strength while you are on the medication.
A regular weight loss clinic typically writes a script and sees you every 3 months. We run advanced labs, track body composition, design resistance training, manage protein intake closely, and check in often through direct messaging. The medication is one tool in a system, not the whole system.
GLP-1 coverage depends on your insurance and your starting numbers. Most plans require a BMI over 30, or over 27 with a related condition like type 2 diabetes or sleep apnea. Coverage rules change often. We help with prior authorizations and explore compounded options when commercial coverage is denied.
Wegovy contains semaglutide, which targets one gut hormone receptor (GLP-1). Zepbound contains tirzepatide, which targets two receptors (GLP-1 and GIP). In head-to-head studies, Zepbound tends to produce slightly more weight loss, around 20% versus 15% on average. Side effect profiles are similar. The right choice depends on insurance, response, and tolerance.
Yes, exercise on GLP-1 medications is essential. Resistance training is the single most important behavior to protect muscle while losing weight. Two to three sessions per week of compound lifts (squat, hinge, push, pull) makes a meaningful difference. Cardio adds heart health benefits but does not protect muscle the same way.
Microdosing GLP-1 medications, which means using doses lower than the FDA-approved range, is being studied for metabolic health and longevity rather than significant weight loss. Some clinicians use it for patients who want metabolic benefits without large appetite changes. Long-term safety and benefit data are still emerging.
Weight loss on GLP-1 medications is typically 1 to 2 pounds per week once you are at a therapeutic dose. The first month is usually slower because doses start low. After 6 months on a stable dose, many patients see total weight loss of 10% to 15%. Faster is not always better; slower loss usually means less muscle loss.
If you miss a weekly GLP-1 dose, take it as soon as you remember if it has been less than 5 days. If more than 5 days have passed, skip it and resume your normal schedule. Do not double up. We help with reminders and adjusting timing if your schedule shifts.

Deep-Dive Questions

"Ozempic face" describes the gaunt, hollow look that some people get during rapid weight loss on GLP-1 medications. It happens because facial fat is lost along with body fat, sometimes faster than skin can adjust. Prevention focuses on slower loss, adequate protein, resistance training, and good hydration. Lost facial volume can sometimes be addressed cosmetically once weight stabilizes.
Visceral fat (the fat around your organs deep in the belly) is metabolically active. It releases inflammatory signals and free fatty acids directly into the liver. This drives insulin resistance, fatty liver disease, and heart disease. Subcutaneous fat (the fat just under the skin) is far less inflammatory. DEXA scans tell us how much of each you have.
Sleep affects weight loss through hormones. Poor sleep raises cortisol and ghrelin (the hunger hormone) and lowers leptin (the fullness hormone). One night of bad sleep can increase next-day food intake by about 300 calories on average. Patients who fix sleep often see better weight outcomes without changing food at all.
Women with stubborn weight often have one or more of: PCOS (polycystic ovary syndrome), insulin resistance, hypothyroidism, perimenopausal hormone shifts, or chronically high cortisol. Standard weight loss advice ignores these. We test, identify the driver, and treat it before assuming the issue is calories.
Leptin resistance is when the brain stops responding properly to leptin, the hormone that signals you have eaten enough. The result is that the brain "thinks" you are starving even when you have plenty of fuel stored. Leptin resistance is common in chronic obesity and is one reason why willpower alone often fails. GLP-1s and improved insulin sensitivity can help reset the signal.
The menstrual cycle affects weight loss through hormone shifts. Most women hold extra water in the second half of their cycle (the luteal phase). Cravings, hunger, and energy levels also shift. Tracking weight monthly rather than daily, and being patient through luteal weeks, prevents false alarms.
You can lose weight in perimenopause, but the strategy needs to change. Estrogen drops shift fat storage to the belly and reduce muscle protein synthesis. Resistance training becomes more important, not less. Sleep, stress, and protein matter even more. GLP-1 medications work in this group too, often with smaller but meaningful results.
The gut microbiome shapes how many calories you extract from food, how much inflammation you carry, and how your appetite hormones work. Patients with low microbial diversity tend to have more weight gain and more insulin resistance. Fiber, fermented foods, and treating dysbiosis (an unhealthy mix of gut bacteria) can support weight goals.
Insulin resistance prevents weight loss by keeping insulin levels high. High insulin tells fat cells to keep storing fat and blocks fat from being released for fuel. Even with a small calorie deficit, weight loss can stall when insulin stays elevated. Lowering carb load, building muscle, and using insulin-sensitizing tools (like metformin) help break this cycle.
GLP-1 medications can cause meaningful muscle loss if not managed well. Studies suggest 20% to 40% of weight lost may come from lean tissue without intervention. With high protein intake (around 1 gram per pound of ideal body weight), resistance training 2 to 3 times per week, and possibly creatine, muscle loss can drop substantially.
Bariatric surgery is sometimes the right answer, especially for severe obesity (BMI over 40, or over 35 with major related conditions) when medications and lifestyle have not worked. Modern procedures like sleeve gastrectomy and gastric bypass produce durable weight loss and metabolic improvement. We coordinate with surgical centers and provide medical management before and after.
Weight regain after loss is common and is not a failure. We treat it as a clinical event. We look for sleep changes, stress increases, hormone shifts, medication changes, or behavior drift. Sometimes restarting a GLP-1, often at a low maintenance dose, holds the new set point. We do not blame patients for biology.
Set point theory says the brain defends a specific body weight by adjusting metabolism and appetite. When you lose weight, the brain raises hunger and lowers metabolism to bring you back. GLP-1 medications appear to lower the defended set point in many patients, which is why long-term weight loss is more achievable with them than with diet alone.
Chronic stress prevents weight loss by keeping cortisol elevated. High cortisol drives insulin resistance, increases visceral fat, raises hunger, and disrupts sleep. Patients who fix stress through breathwork, sleep hygiene, walking, and limited caffeine often see weight start to move after months of stalling.
Compounded versions of semaglutide and tirzepatide became available because of FDA-approved drug shortages. Quality varies by pharmacy. We use compounded options only from licensed compounding pharmacies with strong quality controls, and we are careful about dosing and storage. As name-brand supply has improved, the FDA has limited compounding eligibility.
While on a GLP-1, we retest fasting insulin, A1c (a 3-month average blood sugar marker), lipid panel including ApoB (a marker of heart disease risk), full thyroid panel, kidney function, liver enzymes, and a DEXA scan every 6 to 12 months. We also track grip strength as a marker of muscle health.
Weight comes off easier in the first month because some of the loss is water (especially if carb intake drops) and food in transit. True fat loss is typically 1 to 2 pounds per week at a sustainable pace. Patients who expect rapid scale changes through month 2 often get discouraged when biology slows things down.
Some GLP-1 medications, including Wegovy, are approved for adolescents 12 and older with obesity. Use in this group requires careful evaluation, including mental health screening and family involvement. Long-term effects in growing bodies are still being studied. We coordinate care with pediatrics when this is the right path.

Still have a question?

He answers personally. Usually within a few hours.

Related Intelligence

Ozempic vs. Metformin | Strategic Guide for Metabolic Health

Ozempic vs. Metformin | Strategic Guide for Metabolic Health

Should you start with the foundation (Metformin) or the heavy hitter (GLP-1)? We break down signaling, metabolic impact, and sustainability.

Read Deep Dive
Metabolic Health & Insulin Resistance Philadelphia | Longevity

Metabolic Health & Insulin Resistance Philadelphia | Longevity

Weight is a lagging indicator. Insulin is a leading indicator. We use fasting insulin, CGMs, and DEXA scans to find and fix metabolic dysfunction.

Read Deep Dive
Metabolic Reset & Better Biology | Philadelphia

Metabolic Reset & Better Biology | Philadelphia

A grounded clinical approach to metabolic health and GLP-1s. We focus on biological restoration and body composition, fixing the engine first.

Read Deep Dive

Talk it through with Dr. Ash.

If anything you read here raised a question, this is a free 20-minute Warm Invitation Call. Pick a time and we’ll work through it together.

HSA/FSA eligible
No initiation or cancellation fees
No copays

Loading scheduler...

Having trouble with the scheduler? Book directly on Dr. Ash’s calendar

FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
2418 E York St, Philadelphia, PA 19125Home visits in Greater Philadelphia

Serving Fishtown · Art Museum · Bella Vista · Callowhill · Center City · Center City West · Chestnut Hill · East Kensington · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Northern Liberties · Old City · Olde Richmond · Poplar · Port Richmond · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • TRT Therapy
  • TRT Safety
  • TRT vs Enclomiphene
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical Independence